Key facts
- This page summarizes G. Walmsley Graham's Form 4/A - Amendment filing for Olema Pharmaceuticals, Inc. (OLMA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 13 May 2025, 19:14.
Key filing fact
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
Additional SEC filing notes
Footnote F1
These securities are held by Logos Global Master Fund LP ("Logos Master Fund"). This holding was inadvertently omitted from the Form 4 filed by the reporting person on December 17, 2024. Logos Master Fund did not participate in the transactions reported in that Form 4. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.